RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > The Status of Consumer Drug Advertising in Canada

The Status of Consumer Drug Advertising in Canada

Posted 01 May 2008

Direct-to-Consumer Advertising (DTCA) has become an accepted reality in the US, where at least three types are regularly used to promote prescription drugs.

"Branded" advertisements promote the drug and its therapeutic effects. "Unbranded" advertisements, a.k.a. "talk to your doctor" advertisements, are used to educate consumers about treatment options that may be available, although the drug remains unnamed. Reminder advertisements simply feature the name of the drug, with no mention of therapeutic claims, diseases or conditions.

 

© 2022 Regulatory Affairs Professionals Society.